Elisa Gremese Selected Research

Antimalarials (Antimalarial Agents)

6/2022	Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered.
1/2021	Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?
9/2020	Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Gremese Research Topics

Disease

57	Rheumatoid Arthritis 10/2022 - 06/2004
19	Arthritis (Polyarthritis) 06/2022 - 11/2010
17	Inflammation (Inflammations) 01/2021 - 06/2004
15	Psoriatic Arthritis 01/2022 - 11/2015
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 11/2004
9	COVID-19 01/2022 - 09/2020
9	Infections 09/2020 - 06/2004
8	Necrosis 01/2022 - 07/2006
6	Rheumatic Diseases (Rheumatism) 09/2020 - 06/2010
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2018
5	Adult-Onset Still's Disease 07/2020 - 01/2017
5	Overweight 08/2019 - 05/2014
4	Axial Spondyloarthritis 01/2022 - 11/2015
4	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 01/2018
4	Neoplasms (Cancer) 07/2020 - 01/2018
4	Obesity 08/2019 - 01/2013
3	Joint Diseases (Joint Disease) 05/2022 - 11/2016
3	Lupus Nephritis 11/2021 - 01/2016
3	Synovitis 01/2021 - 07/2017
3	Systemic Scleroderma (Systemic Sclerosis) 12/2020 - 07/2018
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2020 - 01/2017
3	Vasculitis (Vasculitides) 01/2020 - 11/2016
3	Giant Cell Arteritis (Horton Disease) 01/2020 - 04/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 07/2017
2	Hypertension (High Blood Pressure) 11/2021 - 01/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 09/2020 - 12/2018
2	Heart Failure 07/2020 - 01/2019
2	Pulmonary Arterial Hypertension 05/2020 - 01/2019
2	Ankylosing Spondylitis 01/2020 - 03/2007
2	Spondylarthropathies 07/2019 - 01/2019
2	Pain (Aches) 01/2019 - 09/2017
2	Body Weight (Weight, Body) 01/2018 - 05/2014
2	Weight Loss (Weight Reduction) 01/2018 - 07/2016
2	Atherosclerosis 08/2011 - 01/2011
1	Osteoarthritis 01/2022
1	Proteinuria 11/2021
1	Critical Illness (Critically Ill) 10/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2021

Drug/Important Bio-Agent (IBA)

21	Biological ProductsIBA 01/2022 - 06/2004
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020 - 06/2004
11	Antirheumatic Agents (DMARD)IBA 01/2022 - 12/2012
10	Pharmaceutical PreparationsIBA 01/2022 - 06/2012
9	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 05/2014
9	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2011
8	SteroidsIBA 05/2021 - 11/2006
6	ametantrone (HAQ)IBA 05/2021 - 01/2014
6	Rituximab (Mabthera)FDA Link 12/2020 - 12/2014
6	Etanercept (Enbrel)FDA Link 06/2020 - 06/2012
5	C-Reactive ProteinIBA 10/2022 - 01/2011
5	AntibodiesIBA 10/2021 - 06/2010
5	AutoantibodiesIBA 01/2019 - 06/2004
5	Infliximab (Remicade)FDA Link 01/2018 - 03/2007
5	Adalimumab (Humira)FDA Link 07/2017 - 06/2012
4	AutoantigensIBA 06/2022 - 06/2004
4	CytokinesIBA 01/2022 - 09/2011
4	Abatacept (Orencia)FDA Link 01/2022 - 09/2017
4	Ustekinumab (CNTO 1275)FDA Link 01/2022 - 01/2018
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 06/2017
3	Antimalarials (Antimalarial Agents)IBA 06/2022 - 09/2020
3	belimumabIBA 11/2021 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 11/2010
3	Interleukin-1 (Interleukin 1)IBA 01/2020 - 12/2012
3	AntigensIBA 04/2019 - 11/2010
3	InterleukinsIBA 01/2017 - 07/2006
3	AdipokinesIBA 07/2016 - 08/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 05/2021
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2022 - 01/2021
2	Interleukin-12 (IL 12)IBA 01/2022 - 11/2021
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 01/2020
2	sarilumabIBA 10/2021 - 10/2020
2	tocilizumab (atlizumab)FDA Link 10/2021 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2021 - 01/2021
2	CollagenIBA 01/2021 - 12/2015
2	16S Ribosomal RNAIBA 01/2021 - 05/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 11/2015
2	Proteins (Proteins, Gene)FDA Link 03/2020 - 09/2011
2	GlucocorticoidsIBA 01/2020 - 01/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2019 - 04/2019
2	vedolizumabIBA 11/2019 - 01/2019
2	HLA-DRB1*04 antigenIBA 04/2019 - 12/2015
2	Hormones (Hormone)IBA 02/2019 - 01/2019
2	Rheumatoid FactorIBA 01/2019 - 09/2011
2	Immunoglobulin M (IgM)IBA 01/2018 - 09/2011
2	Immunoglobulin A (IgA)IBA 01/2018 - 09/2011
2	amsonic acid (DAS)IBA 07/2017 - 01/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016 - 11/2006
1	Chloroquine (Aralen)FDA LinkGeneric 06/2022
1	SaltsIBA 06/2022
1	GoldIBA 06/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	sortilinIBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	LigandsIBA 01/2022
1	CreatinineIBA 11/2021
1	Monoclonal AntibodiesIBA 10/2021

Therapy/Procedure

33	Therapeutics 01/2022 - 06/2004
4	Biological Therapy 08/2019 - 01/2009
2	Immunotherapy 01/2020 - 12/2019